Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Trelleborg – page 37

453 clinical trials in Trelleborg, Sweden across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Trelleborg at a glance
453
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

453 trials in Trelleborg

Open in trial search

Study of Capivasertib with CDK4/6 Inhibitors and Fulvestrant for Patients with Advanced HR+/HER2- Breast Cancer

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:AstraZeneca AB

Parkinson's disease

Not recruiting

Study on BIA 28-6156 for Parkinson's Disease in Patients with GBA1 Gene Variant

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Pariceract
  • Sponsor:Bial R&D Investments S.A.

Factor IX deficiency

Not recruiting

Study on the Efficacy and Safety of Fidanacogene Elaparvovec Gene Therapy in Adult Males with Moderate to Severe Hemophilia B

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Fidanacogene Elaparvovec
  • Sponsor:Pfizer Inc.

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Study on JNJ-81201887 for Treating Geographic Atrophy in Age-related Macular Degeneration Patients

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Onzemipgene parvec
  • Sponsor:Janssen Cilag International

Study on the Effectiveness and Safety of Ulotaront for Adults with Generalized Anxiety Disorder

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ulotaront
  • Sponsor:Otsuka Pharmaceutical Development & Commercialization Inc.

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Bayer AG

Study on Luspatercept and Epoetin Alfa for Treating Anemia in Patients with Low to Intermediate Risk Myelodysplastic Syndromes Needing Blood Transfusions

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Epoetin Alfa
  • Sponsor:Celgene Corp.

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Hodgkin's disease

Not recruiting

Study Comparing MK-4280A (Favezelimab and Pembrolizumab) with Chemotherapy for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Neoplasm

Not recruiting

Study of Olaparib and Pembrolizumab for Patients with Advanced Cancer with HRRm or HRD Mutations

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:Merck Sharp & Dohme LLC

Study on Dexamethasone Eye Drops for Infants with Retinopathy of Prematurity

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Dexamethasone Phosphate
  • Sponsor:Vastra Gotalandsregionen

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Trelleborg

What the registry says about research in the country

01 Analytical and Diagnostic Research

Clinical trial activity in Trelleborg includes analytical and diagnostic research focused on better understanding treatment response and patient outcomes in everyday practice.

  • Assessment of symptom improvement in allergic rhinitis due to dog allergy
  • Monitoring clinical response to allergen-specific vaccination
  • Evaluation of outcome measures used to track effectiveness in routine care

These studies aim to improve how clinicians identify benefit and measure changes in patients over time.

02 Allergy and Immune System Diseases

One major focus is immune system diseases, especially allergic rhinitis due to dog allergy, with research designed to test whether targeted allergy treatment can reduce symptoms and improve quality of life.

  • Dog allergy and related nasal symptoms
  • Allergen immunotherapy in real-world Swedish practice
  • Long-term relief of allergy-related discomfort

This work explores the effectiveness of a new approach for helping patients manage persistent allergy symptoms.

03 Musculoskeletal Diseases

Another key area is musculoskeletal diseases, particularly research linked to hip arthroplasty and prevention of prosthetic joint infection.

  • Prosthetic Joint Infection after joint replacement
  • Strategies to lower infection risk following hip replacement
  • Support for safer recovery in orthopedic care

The goal is to evaluate whether infection-preventing bone graft treatment can improve outcomes after surgery.

04 Bacterial Infections and Surgical Procedures

Research in bacterial infections and surgical procedures is centered on preventing post-operative complications and improving the success of orthopedic treatment.

  • Prevention of infection in bone graft use
  • Protection against bacteria-related complications after surgery
  • Testing a treatment approach designed to support surgical recovery

These trials help clarify whether infection-focused interventions can make operative care safer and more effective.

05 Musculoskeletal and Neural Physiological Phenomena

The local research profile also reflects interest in musculoskeletal and neural physiological phenomena, with clinical studies examining how the body responds to allergy treatment and orthopedic interventions.

  • Changes in symptoms and function over time
  • Patient response after allergen treatment
  • Recovery patterns following joint replacement

In Trelleborg, these studies aim to connect physiological changes with practical benefits for patients.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.